UBS Group
NRXS icon

UBS Group’s Neuraxis NRXS Stock Holding History

UBS Group’s Portfolio NRXS Stock Details NRXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$260K Sell
35,575
-9,767
-22% -$72.1K ﹤0.01% 6651
2026
Q1 		$336K Sell
45,342
-3,488
-7% -$19.1K ﹤0.01% 6351
2025
Q4 		$222K Buy
+48,830
New +$146K ﹤0.01% 6524
2025
Q3 		– Sell
-575
Closed -$1.39K – 10735
2025
Q2 		$1.39K Sell
575
-1,796
-76% -$4.21K ﹤0.01% 9627
2025
Q1 		$5.1K Buy
2,371
+1,225
+107% +$2.95K ﹤0.01% 9033
2024
Q4 		$2.69K Buy
+1,146
New +$3.22K ﹤0.01% 9002
2024
Q3 		– Sell
-260
Closed -$723 – 9887
2024
Q2 		$723 Buy
260
+45
+21% +$137 ﹤0.01% 8801
2024
Q1 		$671 Buy
+215
New +$637 ﹤0.01% 8424
2023
Q4 		– Sell
-1,699
Closed -$6.46K – 9717
2023
Q3 		$6.46K Buy
+1,699
New +$7.82K ﹤0.01% 7299

Other funds holding NRXS

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCC
Money Concepts Capital Palm Beach Gardens, Florida $2.16B AUM 28.67% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
PC
Panoramic Capital Larkspur, California $232M AUM 255.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

UBS Group's NRXS Position: Q2 2026 in Review

UBS Group reduced its Neuraxis (NRXS) stake by 22% in Q2 2026, selling an estimated $72.1K and leaving 35,575 shares worth $260K. The position accounts for ﹤0.01% of the portfolio, ranked #6651.

UBS Group first reported a position in NRXS in Q3 2023 and has held it in 9 quarters since. The position peaked at $336K in Q1 2026. 32 funds tracked by Wall St. Rank hold NRXS as of Q2 2026.

  • UBS Group held 35,575 shares of Neuraxis worth $260K as of Q2 2026.
  • UBS Group sold 9,767 Neuraxis shares in Q2 2026, an estimated $72.1K.
  • Neuraxis made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #6651 holding.
  • UBS Group first reported a position in Neuraxis in Q3 2023 and has held it in 9 quarters since.
  • UBS Group's Neuraxis position peaked at $336K in Q1 2026.
  • 32 funds tracked by Wall St. Rank held Neuraxis as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.